Ralaniten
Ralaniten (also known as EPI-002) is a nonsteroidal antiandrogen (NSAA) which is under development for the treatment of prostate cancer. It acts as an androgen receptor antagonist and is targeted at the N-terminal domain of the receptor.
Mechanism of Action
Ralaniten works by binding to the N-terminal domain of the androgen receptor. This is a unique mechanism of action compared to other NSAAs, which typically target the ligand-binding domain of the receptor. By targeting the N-terminal domain, Ralaniten can inhibit both the receptor's transcriptional activity and its ability to bind to androgens.
Clinical Trials
Ralaniten has been studied in phase I and II clinical trials for the treatment of prostate cancer. In these trials, it has shown promise in treating patients with castration-resistant prostate cancer, a form of the disease that is resistant to other forms of treatment.
Side Effects
As with all medications, Ralaniten may cause side effects. These can include nausea, fatigue, and diarrhea. However, these side effects are generally mild and manageable.
Future Research
Further research is needed to fully understand the potential of Ralaniten in treating prostate cancer. This includes more extensive clinical trials and studies into its long-term effects.
See Also
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
